Related Experiment Video
Updated: Jul 18, 2026

10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Carbohydrate-based scaffolds in drug discovery
Bernd Becker1, Glenn C Condie, Giang Thanh Le
1Alchemia Ltd, PO Box 6242, Upper Mt Gravatt, Qld 4122, Australia. bbecker@alchemia.com.au
Mini Reviews in Medicinal Chemistry
|December 16, 2006
Summary
Carbohydrate scaffolds are versatile for drug discovery, showing activity against targets like SSTR, integrins, and viruses. These compounds also exhibit antibacterial and herbicidal properties.
Area of Science:
- Carbohydrate chemistry and medicinal chemistry.
Background:
- Carbohydrates serve as effective molecular scaffolds for presenting pharmacophores.
- Carbohydrate-based molecules exhibit diverse biological activities.
Purpose of the Study:
- To highlight the utility of carbohydrate scaffolds in medicinal chemistry.
- To summarize the biological activities of carbohydrate-based compounds.
Main Methods:
- Review of literature on carbohydrate-based pharmacophores.
- Analysis of biological data for carbohydrate derivatives.
Main Results:
- Carbohydrate scaffolds display pharmacophores targeting somatostatin receptors (SSTR), integrins, HIV-1 protease, matrix metalloproteinases (MMP), and multidrug resistance-associated protein (MRP).
- Carbohydrate derivatives also function as RNA binders.
- Demonstrated antibacterial and herbicidal activities of carbohydrate compounds.
Conclusions:
- Carbohydrates are valuable building blocks for developing novel therapeutic agents.
- The versatility of carbohydrate scaffolds supports applications in drug discovery and agrochemicals.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

